BFM
WVE icon

Boothbay Fund Management’s Wave Life Sciences WVE Stock Holding History

Boothbay Fund Management’s Portfolio WVE Stock Details WVE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-17,900
Closed -$131K – 2426
2025
Q3 		$131K Buy
+17,900
New +$145K ﹤0.01% 1702
2020
Q1 		– Sell
-498
Closed -$399K – 1087
2019
Q4 		$399K Buy
+498
New +$12.2K 0.03% 539

Other funds holding WVE

RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
GP
GSK plc London $602M AUM
MC
Maverick Capital Dallas, Texas $11.3B AUM 76.6% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
6CM
683 Capital Management New York $2.04B AUM 94.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
RAM
Readystate Asset Management Chicago, Illinois $2.93B AUM 18.57% 1-Year Est. Return

Boothbay Fund Management's WVE Position: Q2 2026 in Review

Boothbay Fund Management reduced its Wave Life Sciences (WVE) stake by 9.6% in Q2 2026, selling an estimated $102K and leaving 145,000 shares worth $842K. The position accounts for 0.01% of the portfolio, ranked #1211.

Boothbay Fund Management first reported a position in WVE in Q2 2020 and has held it in 17 quarters since. The position peaked at $3.99M in Q4 2025. 239 funds tracked by Wall St. Rank hold WVE as of Q2 2026.

  • Boothbay Fund Management held 145,000 shares of Wave Life Sciences worth $842K as of Q2 2026.
  • Boothbay Fund Management sold 15,311 Wave Life Sciences shares in Q2 2026, an estimated $102K.
  • Wave Life Sciences made up 0.01% of Boothbay Fund Management's portfolio in Q2 2026, its #1211 holding.
  • Boothbay Fund Management first reported a position in Wave Life Sciences in Q2 2020 and has held it in 17 quarters since.
  • Boothbay Fund Management's Wave Life Sciences position peaked at $3.99M in Q4 2025.
  • 239 funds tracked by Wall St. Rank held Wave Life Sciences as of Q2 2026.

Based on Boothbay Fund Management's 13F filing for Q2 2026, filed 14 Aug 2026.